The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine
The Pediatric Infectious Disease Journal, 05/07/2012Fitzwater SP et al.
Pneumococcal conjugate vaccines (PCV)–7 has shown dramatic reduction in disease and mortality rates in the countries in which it has been introduced. The newly introduced 10–valent and 13–valent pneumococcal vaccines are expected to have substantial disease impact, but monitoring is essential to determine their true impact and sustain further introduction of pneumococcal conjugate vaccines.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.